A survey of RVNs carried out by Animalcare has highlighted an opportunity for practices to take a more proactive approach to educating owners about maintaining their pet’s wellbeing and welfare in older age. According to the survey, fewer than three in ten practices currently run senior pet clinics while there was a clear view among all respondents that additional educational resources would be helpful in supporting their efforts to engage with owners of senior pets.
Animalcare is raising awareness of the need to avoid osteoarthritis breakthrough pain, starting with a free virtual CPD event led by RCVS & EBVS European Veterinary Specialist in Anaesthesia & Analgesia, Matt Gurney. The webinar is the first of several communication events that will focus attention on patients owned by the estimated 80% of owners who feel that their pets with canine osteoarthritis (OA) may be suffering from off-days that can be associated with breakthrough pain
Animalcare is excited to launch Daxocox® (enflicoxib, a selective COX-2 inhibitor), the first and only weekly oral NSAID. Daxocox® not only achieves significant improvement of clinical signs associated with the pain of osteoarthritis (OA) in dogs,1,2 but also helps reduce the risk of breakthrough pain.